PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
[41]   THYMIDINE AS A KINETIC AND BIOCHEMICAL MODULATOR OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMAN ACUTE NONLYMPHOCYTIC LEUKEMIA [J].
BLUMENREICH, MS ;
CHOU, TC ;
ANDREEFF, M ;
VALE, K ;
CLARKSON, BD ;
YOUNG, CW .
CANCER RESEARCH, 1984, 44 (02) :825-830
[42]   PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE IN LEUKEMIC-CELLS AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE [J].
LILIEMARK, JO ;
PAUL, CY ;
GAHRTON, CG ;
PETERSON, CO .
CANCER RESEARCH, 1985, 45 (05) :2373-2375
[43]   Pharmacokinetics of N-4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and whole blood after intravenous and oral administration to mice [J].
Rentsch, KM ;
Schwendener, RA ;
Schott, H ;
Hanseler, E .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (11) :1076-1081
[44]   INFLUENCE OF TETRAHYDROURIDINE ON THE PHARMACOKINETICS OF INTRATHECALLY ADMINISTERED 1-BETA-D-ARABINOFURANOSYLCYTOSINE [J].
RICCARDI, R ;
CHABNER, B ;
GLAUBIGER, DL ;
WOOD, J ;
POPLACK, DG .
CANCER RESEARCH, 1982, 42 (05) :1736-1739
[45]   SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF N-4-HEXADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE AND N-4-OCTADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PLASMA AND ERYTHROCYTES [J].
RENTSCH, KM ;
SCHWENDENER, RA ;
SCHOTT, H ;
HANSELER, E .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 673 (02) :259-266
[46]   PHARMACOKINETICS OF ESORUBICIN IN A PHASE-I TRIAL IN PATIENTS WITH ACUTE-LEUKEMIA [J].
RIGGS, CE ;
DUTCHER, JP ;
STRAUMAN, JJ ;
LINK, B ;
WIERNIK, PH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) :193-193
[47]   ANTITUMOR ACTIVITIES OF NEWLY SYNTHESIZED N4-ACYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE [J].
AOSHIMA, M ;
TSUKAGOSHI, S ;
SAKURAI, Y ;
OHISHI, J ;
ISHIDA, T ;
KOBAYASHI, H .
CANCER RESEARCH, 1976, 36 (08) :2726-2732
[48]   DAUNORUBICIN PHARMACOKINETICS AND THE CORRELATION WITH P-GLYCOPROTEIN AND RESPONSE IN PATIENTS WITH ACUTE-LEUKEMIA [J].
GALETTIS, P ;
BOUTAGY, J ;
MA, DDF .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :324-329
[49]   THE INVITRO DETECTION OF 1-B-D-ARABINOFURANOSYLCYTOSINE (ARA-C) INCORPORATION INTO DNA INVIVO DURING THERAPY FOR ACUTE-LEUKEMIA [J].
SPRIGGS, DR ;
ROBBINS, G ;
OHNO, Y ;
MAYER, RJ ;
KUFE, DW .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 :194-194
[50]   PLASMA BETA-THROMBOGLOBULIN VALUES IN THROMBOCYTOPENIC PATIENTS WITH ACUTE-LEUKEMIA [J].
KUTTI, J ;
ZAROULIS, CG ;
KULPA, J ;
REICH, L ;
CLARKSON, BD ;
GOOD, RA .
AMERICAN JOURNAL OF HEMATOLOGY, 1980, 8 (04) :339-345
12345